About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Glenmark Gains US FDA Approval for Lacosamide Tablets

by Bidita Debnath on October 31, 2015 at 11:25 PM
Font : A-A+

 Glenmark Gains US FDA Approval for Lacosamide Tablets

After Glenmark Pharmaceuticals announced that it has received tentative approval by the United States Food & Drug Administration (USFDA) for its Lacosamide tablets in dosages of 50mg, 100mg, 150mg and 200mg, shares of Glenmark Pharmaceuticals were up over 5% at Rs 992 on the Bombay Stock Exchange.

The tablets are the generic version of Vimpat tablets of 50mg, 100mg, 150mg and 200mg of UCB, Inc., the company said in a release. The patent listed in the Orange Book for Vimpat Tablets, 50 mg, 100 mg, 150 mg and 200 mg is scheduled to expire on March 17, 2022.

Advertisement

According to IMS Health sales data for the 12-month period ending September 2015, the Vimpat market achieved annual sales of approximately USD 691 million.

Glenmark's current portfolio consists of 102 products authorized for distribution in the US marketplace and 64 ANDA's pending approval with the USFDA. Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Green Mediterranean Diet may Help Repair Age-Related Brain Damages
Cervical Cancer Awareness Month 2022
Ultra-Low-Fat Diet
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.


Recommended Reading
Sun Pharmaceuticals Recalls 10 Lakh Boxes Of Anti-Allergy Drug From US Market
The anti-allergic drug, Loratadine is an antihistamine used to treat the symptoms of allergies, ......
Embattled Drugmaker Valeant Pharmaceuticals Cuts Ties to Philidor RX
Valeant has lost confidence in Philidor's ability to continue to operate in a manner that is ......
Mumbai-Based Elder Pharmaceuticals To Clear All Dues By Selling Assets
Elder Pharmaceuticals is a major player in the anti-infectives, multi- vitamins, cardiology and ......
Glenmark Pharmaceuticals Inks Pact With Poland Based Celon for Generic Seretide Accuhaler
As per the terms of the agreement, Glenmark has obtained semi-exclusive marketing and distribution ....

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)